EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · IEX Real-Time Price · USD
5.95
+0.18 (3.12%)
May 31, 2024, 4:30 PM EDT - Market closed

EDAP TMS Revenue

EDAP TMS had revenue of $65.80M in the twelve months ending March 31, 2024, with 6.38% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $16.20M with 0.76% year-over-year growth. In the year 2023, EDAP TMS had annual revenue of $67.14M with 14.52% growth.

Revenue (ttm)
$65.80M
Revenue Growth
+6.38%
P/S Ratio
3.36
Revenue / Employee
$214,332
Employees
307
Market Cap
220.77M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202367.14M8.51M14.52%
Dec 31, 202258.63M8.55M17.08%
Dec 31, 202150.07M-733.45K-1.44%
Dec 31, 202050.81M344.40K0.68%
Dec 31, 201950.46M5.42M12.05%
Dec 31, 201845.04M2.14M4.99%
Dec 31, 201742.90M5.42M14.46%
Dec 31, 201637.48M2.45M6.98%
Dec 31, 201535.03M2.62M8.09%
Dec 31, 201432.41M-705.63K-2.13%
Dec 31, 201333.11M-1.27M-3.69%
Dec 31, 201234.38M5.52M19.14%
Dec 31, 201128.86M-2.84M-8.96%
Dec 31, 201031.70M-3.98M-11.17%
Dec 31, 200935.68M3.55M11.06%
Dec 31, 200832.13M-508.42K-1.56%
Dec 31, 200732.64M5.97M22.39%
Dec 31, 200626.66M2.08M8.44%
Dec 31, 200524.59M-5.46M-18.18%
Dec 31, 200430.05M6.79M29.19%
Dec 31, 200323.26M2.32M11.06%
Dec 31, 200220.95M-356.44K-1.67%
Dec 31, 200121.30M-4.21M-16.50%
Dec 31, 200025.51M5.04M24.64%
Dec 31, 199920.47M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Akebia Therapeutics 187.23M
908 Devices 50.73M
Scilex Holding Company 47.05M
Werewolf Therapeutics 16.22M
Ovid Therapeutics 473.54K
Revenue Rankings